CD4 and neoplasm: Strongly reduced tumor resistance of neoHELP-vaccinated mice caused by CD4+ T cell depletion around the time of MC-38 inoculation indicated that neoantigen-specific CD4+ T cells played a major role in the effector phase of the anti-tumor response.